ICA Group Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
ICA Group Wealth Management's BMY Position: Q2 2024 in Review
ICA Group Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 64% in Q2 2024, selling an estimated $114K and leaving 1,410 shares worth $58.6K. The position accounts for 0.04% of the portfolio, ranked #227.
ICA Group Wealth Management first reported a position in BMY in Q1 2022 and has held it in 10 quarters since. The position peaked at $608K in Q1 2022. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- ICA Group Wealth Management held 1,410 shares of Bristol-Myers Squibb worth $58.6K as of Q2 2024.
- ICA Group Wealth Management sold 2,555 Bristol-Myers Squibb shares in Q2 2024, an estimated $114K.
- Bristol-Myers Squibb made up 0.04% of ICA Group Wealth Management's portfolio in Q2 2024, its #227 holding.
- ICA Group Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 10 quarters since.
- ICA Group Wealth Management's Bristol-Myers Squibb position peaked at $608K in Q1 2022.
- 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.